Skip to main content
Clinical Trials/EUCTR2012-002692-34-AT
EUCTR2012-002692-34-AT
Active, not recruiting
Not Applicable

Clinical study for the assessment of safety and efficacy of Bezafibrate as a drug therapy for patients with mitochondrial myopathies - MitoFibrate CT1

niv.-Klinik für Kinder- und Jugendheilkunde0 sites16 target enrollmentFebruary 26, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
mitochondrial disorder
Sponsor
niv.-Klinik für Kinder- und Jugendheilkunde
Enrollment
16
Status
Active, not recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 26, 2013
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niv.-Klinik für Kinder- und Jugendheilkunde

Eligibility Criteria

Inclusion Criteria

  • Ability to walk
  • Age: 2\-50 years
  • confirmed Complex\-I\-defect or PDHc\-defect
  • ability to cope with the requirements for study participation
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 8
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 8
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • previously known intolerance or other contra\-indications for bezafibrat

Outcomes

Primary Outcomes

Not specified

Similar Trials